Cardiovascular risk reduction — MCCQE Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Statin therapy
CCS Dyslipidemia: intermediate risk (FRS 10-19%) with LDL >3.5 or family history of premature CAD warrants statin. CCS 2021: ASA NOT recommended for primary prevention. Ezetimibe add-on if LDL target not met.
Reference: CCS Dyslipidemia 2021